People with post-traumatic stress disorder (PTSD) face a higher risk of heart disease at an earlier age than people without PTSD. A new study helps explain why.
Apr 27, 2020
0
3
Researchers report evidence that the compounds in e-cigarette liquid could potentially cause the body's tissue repair process to go haywire and lead to scarring inside the lungs. The new study, conducted in cell cultures, ...
Apr 27, 2020
0
3
Zika virus is capable of replicating and spreading infectious particles within the outermost cells lining the vaginal tract, according to new research. The findings provide the first molecular-level insights into how the ...
Apr 27, 2020
0
2
The drug buprenorphine reduces relapse in patients with opioid addiction, and some emerging evidence indicates it may also help treat cocaine addiction. However, the treatment itself comes with a risk of addiction and, thus, ...
Apr 27, 2020
0
0
Researchers have created 3-D tissue structures that recapitulate many aspects of specific human brain regions. These tiny, brain-region specific spheroids are allowing scientists to study previously inaccessible aspects of ...
Apr 27, 2020
0
0
Researchers have used threads made of engineered human tissue to weave blood vessels that could one day help repair diseased or damaged blood vessels.
Apr 27, 2020
0
1
New research finds that nicotine-filled e-cigarettes cause increases in heart rate and blood pressure in young people, health issues that remain even after a vaping session. The research, originally slated for presentation ...
Apr 27, 2020
0
5
Obesity has been shown to place physical stress on the body, but new research suggests that excess weight may also cause mental fatigue. The research, originally slated for presentation at the APS annual meeting at Experimental ...
Apr 27, 2020
0
2
A new study calls into question the reliance on disease-free laboratory mice for testing new influenza (flu) vaccines. Instead, studying mice that have been exposed to other illnesses could help make vaccine development processes ...
Apr 27, 2020
0
1
New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) ...
Apr 27, 2020
0
1
